Here are Wednesday's biggest analyst calls: Nvidia, Apple, Netflix, Nike, Disney, Micron, Walmart, Zillow, FedEx & more

Major financial firms issued numerous rating adjustments, with Netflix, Nvidia (citing AI leadership and undervaluation with a $205 price target), and AbbVie receiving upgrades based on strong engagement, growth prospects, and R&D returns. Conversely, Progressive and FedEx were downgraded due to declining revenue and demand headwinds, while Eli Lilly moved to Hold as the obesity market's upgrade cycle plateaued. Analysts also reiterated positive outlooks for Apple, McDonald's, Micron (with a $180 price target on AI tailwinds), and Walmart, reflecting varied sector-specific drivers and market confidence.

Analysis

Wall Street sentiment appears broadly bullish but highly selective, with a clear focus on specific growth narratives, particularly in Artificial Intelligence. Analysts are signaling strong conviction in AI beneficiaries, evidenced by Daiwa upgrading Nvidia to outperform with a price target increase to $205, citing undervaluation, and Wolfe raising its Micron target to $180 on AI-driven memory demand. This theme extends to infrastructure, with Wolfe upgrading MasTec to outperform as a data center beneficiary. In contrast, sentiment on consumer-facing companies is bifurcated. Netflix earned a Buy upgrade from Loop based on "exceptional 3Q engagement," while value-focused firms like Kroger and Walmart received positive reinforcement on expectations of gaining consumer share. Conversely, significant headwinds are noted in cyclical sectors, leading to downgrades for Progressive (PGR) due to a "declining revenue trend" and FedEx (FDX) on "demand headwinds." The healthcare sector also shows a key divergence, with Berenberg upgrading AbbVie to Buy with a $270 target, citing a "winning" formula, while simultaneously downgrading Eli Lilly to Hold on the view that the obesity market's upgrade cycle has "plateaued."

Key Decisions for Investors

• Investors should consider overweighting exposure to the AI infrastructure theme, particularly through leaders like Nvidia and key component suppliers like Micron, given multiple price target upgrades and strong analyst conviction in the growth narrative.
• A pair trade in the biopharma sector may be warranted, favoring companies with strong R&D returns and valuation upside like AbbVie, while potentially reducing exposure to names like Eli Lilly where analysts perceive the growth cycle and consensus expectations have become elevated.
• Selectivity in consumer stocks is crucial; prioritize companies demonstrating strong user engagement like Netflix or a clear value proposition like Kroger and Walmart, which are positioned to capture consumer spending in the current environment.
• Closely monitor companies in cyclically exposed sectors like logistics and insurance, as the downgrades for FedEx and Progressive on revenue and demand headwinds could be leading indicators of broader economic pressure or heightened competitive risks.